Cultural differences in acceptability of a vaginal microbicide: a comparison between potential users from Nashville, Tennessee, USA, and Kafue and Mumbwa, Zambia
Valerie Montgomery Rice,1 Margaret C Maimbolwa,2 Esther Munalula Nkandu,2 Jacqueline Fleming Hampton,3,* Jae-Eun Lee,4 James EK Hildreth5
1Morehouse School of Medicine, Atlanta, GA, USA; 2School of Medicine, University of Zambia, Lusaka, Zambia; 3Meharry Medical College, Center for AIDS Health Disparities Research, Nashville, TN, USA; 4RCMI Translational Research Network Data and Technology Coordinating Center, Jackson State University, Jackson, MS, USA; 5Dean, College of Biological Sciences, University of California Davis, Davis, CA, USA
Note: at the time the research was conducted, Dr Montgomery Rice was the Executive Director, Center for Women's Health Research, Meharry Medical College, Nashville, TN, USA, and Dr Hildreth was the Director, Center for AIDS Health Disparities Research, Meharry Medical College, Nashville, TN
*Dr Fleming Hampton has passed away since this manuscript was written. We wish to honor her memory by including her as an author
Purpose: We sought to determine the relationship between acceptability of a hypothetical vaginal microbicide, cultural factors, and perceived HIV risk among African-American women in Nashville, TN, USA, and African women in Kafue and Mumbwa, Zambia.
Patients and methods: Women in both sites completed a survey. Regression analyses were performed on valid samples (Nashville, 164; Zambia, 101) to determine cultural differences affecting microbicide acceptability. Regression analyses also tested whether individual risk perception affected acceptability.
Results: In Zambia, 89.6% of women were willing to use a microbicide versus 81.6% in Nashville (P < 0.0001). One cultural difference is that women in the Zambian cohort viewed risk of HIV infection as distinct from risk of acquiring STIs, with 48% believing they were certain to become infected with AIDS, compared to 4% of Nashville participants.
Conclusion: These results suggest a high degree of acceptability toward use of a vaginal microbicide to prevent HIV infection.
Keywords: HIV/AIDS, women, birth control, sexually transmitted infections
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]